Correlation of serum lactate dehydrogenase and pregnancy induced hypertension with its adverse outcomes


  • Liggy Andrews GMERS medical college, Dharpur, Patan, Gujarat
  • Nikunj Patel GMERS medical college, Dharpur, Patan, Gujarat



LDH, Preeclampsia, Perinatal outcomes


Background: Pregnancy induced hypertension (PIH) is a global problem with a 5-15% incidence rate in India and complicating 10-17% of all pregnancies. The complications of PIH are responsible for significant maternal and perinatal morbidity and are the third leading cause of pregnancy related death. Lactate dehydrogenase (LDH) serves as indicators suggestive of disturbance of cellular integrity induced by pathological conditions and is used to detect cell damage or cell death. The main objective was to assess significance of the value of serum LDH as a marker of PIH and its severity.

Methods: Serum LDH was analyzed by modified UV Kinetic IFCC method. This study was conducted from February 2014 to June 2015 and all the patients admitted in the department of obstetrics and gynecology and biochemistry, at the GMERS medical college, Dharpur, Patan, Gujarat, India.

Results: Total 110 cases were studied during the study period, 40 were normal pregnant women and remaining 70 were PIH cases. Out of the 70 PIH cases, 15 (21.5%) were mild preecclampsia, 35 (50.0%) were severe preeclampsia and 20 (28.5%) were eclampsia. Maternal mortality occurred in 06 cases (8.5%). Perinatal mortality was seen in 28 (40.0%), Out of these, 20 (71.4%) were stillbirth and 08 (28.6%) were neonatal deaths. There is significant rise in the LDH levels with the increasing severity of the disease (172.37±28.09) normotensive, (356.33±24.47) mild preeclampsia, (609.91±136.92) severe preeclampsia and (854.05±247.45), eclampsia (P<0.0001). Perinatal deaths occurred in 28 cases, out of these 06 (21.5%) had LDH levels <600 IU/l, 8 (28.5%) had LDH levels between 600-800 IU/l and 14 (50%) had LDH levels >800 IU/l.

Conclusions: Serum LDH showed significant association with severity of disease and maternal and fetal complications in patients with preclampsia-eclamapsia.


Dutta DC. Textbook of Obstetrics. 7th rev ed. New Central BookAgency Priv. Ltd. 2014: 219-40.

Shah MR. Hypertensive disorders in pregnancy. 1st edn published by Jaypee. 2007:1-10.

Mackey AP, Berg CJ, Atrash HK. Pregnancy related mortality from preeclampsia and eclampsia. Am J Obstet Gynecol. 2001;97(4):533-8.

Noris M, Perico N, Remuzzi G. Mechanisms of disease: Pre-eclampsia. Nature Clinical Practice Nephrology. 2005;1(2):98-114.

Mustafa M, Ahmed S, Gupta A, Veunto RC. A comprehensive review of Hypertension in Pregnancy. Journal of Pregnancy. 2012:ArticleID 105918.

Qublan HS, Amarun V, Bateinen O, Al-Shraideh Z, Tahat Y, Awamleh I, et al. LDH as biochemical marker of adverse pregnancy outcome in severe preeclampsia. Med Sci Monit. 2005;11:393-7.

Pennington KA, Schlitt JM, Jackson DL, Schulz LC, Schust DJ. Preeclampsia: multiple approaches for a multifactorial disease. Dis Model Mech. 2012;5(1):9-18.

NICE clinical guideline 107. Hypertension in pregnancy: The management of hypertensive disorders during pregnancy. Available from: nicemedia/ live/13098/ 50418/ 50418.pdf.

Commission Enzymology Lactate dehydrogenase. Ann Biol Clin. 1982;40:123-8.

Malvino E, Munoz M, Ceccotti C, Janello G, McLounghlin D, Pawlak P, et al. Maternal morbidity and perinatal mortality in HELLP syndrome, multicentric studies in intensive care units Buenos Aires area. Medicina (B. Aires). 2005;65(1):17-23.

Jaiswar SP, Amrit G, Rekha S, Natu SN, Mohan S. Lactic Dehydrogenase: A biochemical marker for preeclampsia-eclampsia. JOGI. 2011;61(6):645-8.

Sarmah J. Evaluation of serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), lactate dehydrogenase (LDH) and uric acid in preeclampsia. IOSR Journal of Dental and Medical Sciences. 2015;14(6):10-12.

Sarkar PD, Sogani S. Evaluation of serum lactate dehydrogenase and gamma glutamyl transferase in preeclamptic pregnancy and its comparison with normal pregnancy in third trimester. Int J Res Med Sci. 2013;1(4):365-8.

Demir SC, Evruke C, Ozgunen FT, Urunsak IF, Candan E, Kadayifci O. Factors that influence morbidity, and mortality in severe preeclampsia, eclampsia and HELLP syndrome. Saudi Med J. 2006;27:1015-8.

Umasatyasri Y, Vani I, Shamita P. Role of LDH (Lactate dehydrogenase) in preeclampsia marker: An observational study. IAIM. 2015;2(9):88-93.

He S, Bremme K, Kallner A, Blombäck M. Increased concentrations of lactate dehydrogenase in pregnancy with preeclampsia; a predictor for birth of small for gestational age infants. Gynecol Obstet Invest. 1995;39:234-8.

Bera S, Gupta S, Saha S, Kunti S, Soumi Biswas S, Ghosh D. Study of liver enzymes especially lactate dehydrogenase to predict foetal outcome in pregnancy induced hypertension. Sch J App Med Sci. 2014;2(5A):1569-72.




How to Cite

Andrews, L., & Patel, N. (2016). Correlation of serum lactate dehydrogenase and pregnancy induced hypertension with its adverse outcomes. International Journal of Research in Medical Sciences, 4(5), 1347–1350.



Original Research Articles